Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Mallinckrodt
McKesson
Merck
AstraZeneca

Last Updated: April 5, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Iodophenyl


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Iodophenyl?

Iodophenyl is an investigational drug.

There have been 9 clinical trials for Iodophenyl. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2009.

The most common disease conditions in clinical trials are Parkinson Disease, Behavior, Addictive, and Acute Coronary Syndrome. The leading clinical trial sponsors are Cellectar Biosciences, Inc., Section of Biostatistics University of Copenhagen, Copenhagen, and Pfizer.

Recent Clinical Trials for Iodophenyl
TitleSponsorPhase
Trametinib and TAS-102 in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCity of Hope Medical CenterPhase 1
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Neurobiology Research Unit, Rigshospitalet, CopenhagenPhase 2
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Section of Biostatistics University of Copenhagen, CopenhagenPhase 2

See all Iodophenyl clinical trials

Clinical Trial Summary for Iodophenyl

Top disease conditions for Iodophenyl
Top clinical trial sponsors for Iodophenyl

See all Iodophenyl clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Boehringer Ingelheim
Express Scripts
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.